Though the relationship between SMAD4 and miR-21 in PDAC has not been established, recent studies have shown that miR-21 inhibits the SMAD4 signaling pathway in hepatitis [218] and rheumatoid arthritis [219]. Here, SMAD4 is linked to rheumatoid arthritis.